Progression in the LRRK2-Associated Parkinson Disease Population

IMPORTANCE: Few prospective longitudinal studies have evaluated the progression of Parkinson disease (PD) in patients with the leucine-rich repeat kinase 2 (LRRK2 [OMIM 609007]) mutation. Knowledge about such progression will aid clinical trials. OBJECTIVE: To determine whether the longitudinal cour...

詳細記述

保存先:
書誌詳細
出版年:JAMA Neurol
主要な著者: Saunders-Pullman, Rachel, Mirelman, Anat, Alcalay, Roy N., Wang, Cuiling, Ortega, Roberto A., Raymond, Deborah, Mejia-Santana, Helen, Orbe-Reilly, Martha, Johannes, Brooke A., Thaler, Avner, Ozelius, Laurie, Orr-Urtreger, Avi, Marder, Karen S., Giladi, Nir, Bressman, Susan B.
フォーマット: Artigo
言語:Inglês
出版事項: American Medical Association 2018
主題:
Original Investigation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5885854/
https://ncbi.nlm.nih.gov/pubmed/29309488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2017.4019
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料